In VivoAt its core, Mirum Pharma is a business development success story. CEO Chris Peetz sat down with In Vivo to discuss Mirum’s commercial momentum, near-term catalysts and the company’s vision for beco
ScripA few months after restructuring to conserve cash and put primary focus on its lead candidate BDTX-1535 in first-line non-small cell lung cancer, Black Diamond Therapeutics found a lifeline in Servier
ScripAustralian biotechs Certa Therapeutics and OccuRx are combining their assets under one company in a bid to become a leading player in the fibrotic diseases space. Certa’s acquisition of fellow Melbo
In VivoIn April 2024 Citeline’s Scrip publication reviewed the internal and external R&D inputs of the top 15 companies by sales of prescription and over-the-counter drugs in 2023. This analysis reve